Join
Live feed
·
INSIDERFilingvia Quantisnow
Oric Pharmaceuticals Inc. logo

Director Heyman Richard A. sold $3,600 worth of shares (300 units at $12.00) as part of a pre-agreed trading plan (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ORIC· Oric Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ORIC (Oric Pharmaceuticals Inc.) and more on Quantisnow.